1358 Results for "

highly potent

" in MedChemExpress (MCE) Product Catalog:
Products (1358)

1358 Results for "highly potent" in MCE Product Catalog:

251
251 Publications Verification
Cat. No.: HY-15531
CAS No.: 1257044-40-8
Purity:  99.95%
Synonyms: ABT-199; GDC-0199; RG7601
Target:  

Bcl-2 Family Autophagy

Research Areas:  

Cancer

Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy .
loading...
    loading...
179
179 Cited Publications
Cat. No.: HY-10181A
CAS No.: 854001-07-3
Purity:  98.86%
Synonyms: BMS-354825 hydrochloride
Research Areas:  

Cancer

Dasatinib (BMS-354825) hydrochloride is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib hydrochloride inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib hydrochloride also induces apoptosis and autophagy.
loading...
    loading...
179
179 Cited Publications
Cat. No.: HY-10181B
CAS No.: 863127-77-9
Purity:  99.58%
Synonyms: BMS-354825 monohydrate
Research Areas:  

Cancer

Dasatinib (BMS-354825) monohydrate is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib monohydrate inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib monohydrate also induces apoptosis and autophagy.
loading...
    loading...
179
179 Cited Publications
Cat. No.: HY-10181
CAS No.: 302962-49-8
Purity:  99.83%
Synonyms: BMS-354825
Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively. Dasatinib also induces apoptosis and autophagy, and can cross the blood-brain barrier .
loading...
    loading...
132
132 Cited Publications
Cat. No.: HY-13434
CAS No.: 56092-81-0
Purity:  99.27%
Synonyms: SQ23377
Ionomycin (SQ23377) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin (SQ23377) is highly specific for divalent cations (Ca>Mg>Sr=Ba). Ionomycin (SQ23377) promotes apoptosis. Ionomycin also induces the activation of protein kinase C (PKC) .
loading...
    loading...
132
132 Cited Publications
Cat. No.: HY-13434A
CAS No.: 56092-82-1
Purity:  98.02%
Synonyms: SQ23377 calcium
Ionomycin calcium (SQ23377 calcium) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin calcium (SQ23377 calcium) is highly specific for divalent cations (Ca>Mg>Sr=Ba). Ionomycin (SQ23377) promotes apoptosis. Ionomycin calcium (SQ23377 calcium) also induces the activation of protein kinase C (PKC) .
loading...
    loading...
113
113 Cited Publications
Cat. No.: HY-134836
CAS No.: 2499663-01-1
Purity:  99.86%
Target:  

Apoptosis METTL3

Research Areas:  

Cancer

STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be used for the research of acute myeloid leukaemia (AML) .
loading...
    loading...
106
106 Cited Publications
Cat. No.: HY-16106
CAS No.: 1207456-01-6
Synonyms: BMN-673; LT-673
Target:  

PARP

Research Areas:  

Cancer

Talazoparib (BMN-673) is a highly potent, orally active PARP1/2 inhibitor.Talazoparib inhibits PARP1 and PARP2 enzyme activity with Kis of 1.2 nM and 0.87 nM, respectively. Talazoparib has antitumor activity .
loading...
    loading...
104
104 Cited Publications
Cat. No.: HY-13470
CAS No.: 1346574-57-9
Purity:  99.76%
Synonyms: GSK2816126A
Research Areas:  

Cancer

GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM .
loading...
    loading...
87
87 Cited Publications
Cat. No.: HY-10619B
CAS No.: 1038915-73-9
Purity:  99.99%
Synonyms: MK-4827 tosylate
Target:  

PARP Apoptosis

Research Areas:  

Cancer

Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. Niraparib tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity .
loading...
    loading...
87
87 Cited Publications
Cat. No.: HY-10619
CAS No.: 1038915-60-4
Purity:  99.96%
Synonyms: MK-4827
Target:  

PARP Apoptosis

Research Areas:  

Cancer

Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity .
loading...
    loading...
87
87 Cited Publications
Cat. No.: HY-10619A
CAS No.: 1038915-64-8
Purity:  99.41%
Synonyms: MK-4827 hydrochloride
Target:  

PARP Apoptosis

Research Areas:  

Cancer

Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity .
loading...
    loading...
86
86 Cited Publications
Cat. No.: HY-10619E
CAS No.: 1613220-15-7
Purity:  99.97%
Synonyms: MK-4827 tosylate hydrate
Target:  

PARP Apoptosis

Research Areas:  

Cancer

Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib tosylate hydrate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity .
loading...
    loading...
86
86 Cited Publications
Cat. No.: HY-42110
CAS No.: 1977-07-7
Target:  

mAChR

Research Areas:  

Neurological Disease

Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist, with blood-brain barrier permeability. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively. [ 11C]-Deschloroclozapine is developed as a promising PET tracer for DREADD imaging .
loading...
    loading...
86
86 Cited Publications
Cat. No.: HY-42110A
Target:  

mAChR

Research Areas:  

Neurological Disease

Deschloroclozapine dihydrochloride, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist, with blood-brain barrier permeability. Deschloroclozapine dihydrochloride binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively. [ 11C]-Deschloroclozapine dihydrochloride is developed as a promising PET tracer for DREADD imaging .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-15392
CAS No.: 1273579-40-0
Purity:  99.42%
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

Chroman 1 is a highly potent and selective ROCK inhibitor. Chroman 1 is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 also has inhibitory activity against MRCK, with an IC50 of 150 nM .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-15392A
Purity:  99.11%
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

Chroman 1 dihydrochloride is a highly potent and selective ROCK inhibitor. Chroman 1 dihydrochloride is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 dihydrochloride also has inhibitory activity against MRCK, with an IC50 of 150 nM .
loading...
    loading...
66
66 Cited Publications
Cat. No.: HY-12016
CAS No.: 587871-26-9
Purity:  99.92%
Target:  

ATM/ATR Autophagy

Research Areas:  

Cancer

KU-55933 is a potent ATM inhibitor with an IC50 and Ki of 12.9 and 2.2 nM, respectively, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.
loading...
    loading...
59
59 Cited Publications
Cat. No.: HY-50855B
CAS No.: 1309357-15-0
Synonyms: CX-4945 sodium salt
Target:  

Casein Kinase Autophagy

Research Areas:  

Cancer

Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
loading...
    loading...
59
59 Cited Publications
Cat. No.: HY-50855
CAS No.: 1009820-21-6
Synonyms: CX-4945
Target:  

Casein Kinase Autophagy

Research Areas:  

Cancer

Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
loading...
    loading...